Enteropathogenic Escherichia coli (EPEC) inactivate innate immune responses prior to compromising epithelial barrier function.
about
Bacterial effector binding to ribosomal protein s3 subverts NF-kappaB functionEnteric infection meets intestinal function: how bacterial pathogens cause diarrhoeaThe Structure and Specificity of the Type III Secretion System Effector NleC Suggest a DNA Mimicry Mechanism of Substrate RecognitionMetalloprotease type III effectors that specifically cleave JNK and NF-κBThe enteropathogenic E. coli effector EspF targets and disrupts the nucleolus by a process regulated by mitochondrial dysfunctionThe enteropathogenic E. coli (EPEC) Tir effector inhibits NF-κB activity by targeting TNFα receptor-associated factorsNck adaptors, besides promoting N-WASP mediated actin-nucleation activity at pedestals, influence the cellular levels of enteropathogenic Escherichia coli Tir effector.Secretion of flagellin by the LEE-encoded type III secretion system of enteropathogenic Escherichia coli.The type III effectors NleE and NleB from enteropathogenic E. coli and OspZ from Shigella block nuclear translocation of NF-kappaB p65.NleC, a type III secretion protease, compromises NF-κB activation by targeting p65/RelAEnteropathogenic Escherichia coli inhibits type I interferon- and RNase L-mediated host defense to disrupt intestinal epithelial cell barrier functionRole of EscU auto-cleavage in promoting type III effector translocation into host cells by enteropathogenic Escherichia coliBacterial-epithelial contact is a key determinant of host innate immune responses to enteropathogenic and enteroaggregative Escherichia coli.New concepts of microbial translocation in the neonatal intestine: mechanisms and prevention.Enteropathogenic and enterohaemorrhagic Escherichia coli: even more subversive elements.Recent advances in understanding enteric pathogenic Escherichia coli.The effector repertoire of enteropathogenic E. coli: ganging up on the host cellMetalloprotease NleC suppresses host NF-κB/inflammatory responses by cleaving p65 and interfering with the p65/RPS3 interactionAttaching and effacing bacterial effector NleC suppresses epithelial inflammatory responses by inhibiting NF-κB and p38 mitogen-activated protein kinase activation.HilA-like regulators in Escherichia coli pathotypes: the YgeH protein from the enteroaggregative strain 042Correlating levels of type III secretion and secreted proteins with fecal shedding of Escherichia coli O157:H7 in cattle.Enteropathogenic E. coli non-LEE encoded effectors NleH1 and NleH2 attenuate NF-κB activation.The Type III Effector NleD from Enteropathogenic Escherichia coli Differentiates between Host Substrates p38 and JNK.The NleE/OspZ family of effector proteins is required for polymorphonuclear transepithelial migration, a characteristic shared by enteropathogenic Escherichia coli and Shigella flexneri infections.Microbiological Quality Assessment by PCR and Its Antibiotic Susceptibility in Mangrove Crabs (Ucides cordatus) from Guanabara Bay, Rio de Janeiro, Brazil.Prolonged NF-κB activation by a macrophage inhibitory cytokine 1-linked signal in enteropathogenic Escherichia coli-infected epithelial cells.Role of NleH, a type III secreted effector from attaching and effacing pathogens, in colonization of the bovine, ovine, and murine gut.Enteropathogenic Escherichia coli subverts phosphatidylinositol 4,5-bisphosphate and phosphatidylinositol 3,4,5-trisphosphate upon epithelial cell infectionProtective and destructive innate immune responses to enteropathogenic Escherichia coli and related A/E pathogens.Pathogenesis of human enterovirulent bacteria: lessons from cultured, fully differentiated human colon cancer cell linesEnterohemorrhagic Escherichia coli suppresses inflammatory response to cytokines and its own toxin.Always one step ahead: How pathogenic bacteria use the type III secretion system to manipulate the intestinal mucosal immune system.Infection strategies of enteric pathogenic Escherichia coli.Interleukin-8, CXCL1, and MicroRNA miR-146a Responses to Probiotic Escherichia coli Nissle 1917 and Enteropathogenic E. coli in Human Intestinal Epithelial T84 and Monocytic THP-1 Cells after Apical or Basolateral Infection.Modulation of host signaling in the inflammatory response by enteropathogenic Escherichia coli virulence proteins.Do Caco-2 subclones provide more appropriate in vitro models for understanding how human enteric pathogens cause disease?The pathogenic Escherichia coli type III secreted protease NleC degrades the host acetyltransferase p300.The flagella of an atypical enteropathogenic Escherichia coli strain are required for efficient interaction with and stimulation of interleukin-8 production by enterocytes in vitro.Flagellin Induces β-Defensin 2 in Human Colonic Ex vivo Infection with Enterohemorrhagic Escherichia coli.Identification of a Distinct Substrate-binding Domain in the Bacterial Cysteine Methyltransferase Effectors NleE and OspZ.
P2860
Q24293521-E3C44DE8-79C5-40FC-8C01-5838F57E2282Q24596978-E788957B-163A-4826-94BE-2CE6A32AA41FQ27684732-136B594A-4CCD-4323-809E-65418FF5A3F6Q28116010-2C6C6862-8C77-4FBA-8E56-46DD7377E749Q28474712-FF304D6B-4864-4CE5-8F0A-7F1F3B9D1209Q28478223-A4B0C4D3-9771-4CC2-9526-C84021CC1238Q30009263-BD095B92-112C-49CB-AED7-5B5ADFAE5236Q33406647-88116E12-3721-4DD1-9C50-D48F2362DEBBQ33582255-B8917D5F-77D3-432C-BA50-40D8054AD842Q33780981-DB3D2C2E-FCC5-499E-A62B-5DF0341E08E2Q33899677-E9E8A3B2-E8F4-43F3-B944-CE27F57C710CQ34024603-EA3F560F-4031-4E2F-B49D-A74677B4DE4BQ34064916-01D0B1D6-75E2-4C60-A677-69110FAEF22BQ34104407-D7D640AF-5E95-46FC-AD43-6830BD702816Q34177961-1270A53C-9208-4314-B8BB-C77653E6188AQ34375210-152E8A08-EC7C-4747-91F0-E8A39791D67CQ34921824-B2BCBE15-55F8-4603-87EE-EF82BDA1D62EQ35163621-C9E6F1D0-35CE-4D15-9F7F-68D799E81E5CQ35191956-C57713E7-B0F5-4058-A348-8AAF83474DC4Q35365637-A37BE518-D6F1-432F-9957-7BF725BDDA79Q35867616-82D97D10-AC31-4961-A5DA-9AB919EC7B92Q35886703-74E0C363-A241-47BC-B487-02F81055CFD7Q36200507-98D559B1-C838-49A6-BC76-672DCF9CBD75Q36422115-9E4BB616-13E6-47A2-A2EA-EBC001CEB4F1Q36737826-19A202F4-DC3F-412B-920A-67801DF176EEQ36911360-90E2155F-27AC-4D89-B533-31D7E5DF1E2DQ36950038-470791F9-F27F-4256-905C-5108B3DBD230Q37034994-D853CA26-F745-4D8A-BA3C-1B7CD14DF1ADQ37174121-81DDE369-7B52-4792-8894-4DFE4D8EEA9FQ37264192-0BB66145-34D7-48DE-AE9D-E517A2348748Q37337686-CA4B5E77-3217-40A0-A095-846D2023F0B3Q37871646-BA59B7C0-838C-4F40-A1C5-352197413C3BQ38007348-AD7B19C3-BBCF-42BE-B59B-3B341546D3F0Q38764707-EFF487CA-BB41-4733-8D72-D6F0C73B4850Q38994595-9B681656-CAE4-4C9E-B5AD-2C8FA8FA800EQ39413863-FBD6ADAB-57AE-4417-A57C-A22065CFD794Q39495822-6ACD4EC5-2469-4A44-958B-74C0E889BEA8Q39822827-B460A19E-A04C-496D-9175-524953A96374Q40603856-1CE168FE-B795-4D6A-BD60-5C08A773CF53Q40604251-02E15A59-942A-4BB4-86B7-6F82501C7526
P2860
Enteropathogenic Escherichia coli (EPEC) inactivate innate immune responses prior to compromising epithelial barrier function.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Enteropathogenic Escherichia c ...... g epithelial barrier function.
@en
type
label
Enteropathogenic Escherichia c ...... g epithelial barrier function.
@en
prefLabel
Enteropathogenic Escherichia c ...... g epithelial barrier function.
@en
P2860
P1476
Enteropathogenic Escherichia c ...... ng epithelial barrier function
@en
P2093
Brendan Kenny
Marie-Hélène Ruchaud-Sparagano
P2860
P304
P356
10.1111/J.1462-5822.2007.00923.X
P50
P577
2007-03-26T00:00:00Z